rss
Evid Based Nurs doi:10.1136/eb-2013-101502
  • Women’s health
  • Systematic review

Drospirenone-containing oral contraceptives may increase the risk of venous thromboembolism

  1. Susan S Jick
  1. Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Lexington, Massachusetts, USA
  1. Correspondence to: Dr Susan S Jick, Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, 11 Muzzey Street, Lexington, MA 02421, USA; sjick{at}bu.edu

Commentary on:

Implications for practice and research

  • The risk of arterial thrombosis (AT) is very low in all oral contraceptive pills (OCPs)

  • Risks of venous thromboembolism (VTE) vary according to the progestin type

  • Drospirenone OCPs confer a higher risk of VTE than levonorgestrel OCPs

Context

That OCPs increase the risk of venous and arterial thrombosis has been well recognised and well researched since OCPs were first marketed. Since the earliest reporting of the high risk of VTE (deep vein thrombosis and pulmonary embolism) in OCP users, the doses and formulations of both the oestrogen and progestin components of OCPs have changed, initially resulting in a decrease in the risk of thrombotic events, and later leading to differences in risk between OCPs. However, the following questions remain: what are the risks of thrombotic …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article